Florida · Nonprofit
SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC
SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC (Florida) receives grants from 4 organizations whose IRS filings report $408,896 to it, the largest being Pediatric Brain Tumor Foundation of the United States Inc ($222,633). 4 of them have funded it in more than one year.
- Revenue FY2024
- $321k
- Funders on record
- 4
- Grants received
- $409k
- Net assets
- $546k
What Sydney's Incredible Defeat of Ewing's Sarcoma Inc does
Mission
1)fund research specialists to find a cure for ewing's sarcoma.2)fund research specialists to devise less painful treatment methods for ewings's sarcoma.3)provide financial assistance to families going through the treatment process for ewing's sarcoma.4)financially assist other charitable organizations that support families affected by pediatric cancer.
As stated on its FY2021 Form 990.
Program
Sides provides financial assistance to families that suffer from ewings sarcoma
$120,483 spent$320,100 earned by the program100% of program spending
The program described on its FY2024 Form 990. Program spending in total: $120,483.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $141k to $409k (+191%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
100% of SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC’s revenue is contributions — more donation-reliant than the typical peer (82% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2017 → 2023: the base broadened from 1 funder to 3 funders, grant income rose $15k → $37k.
2 of 4 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 12% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC leans on a few funders — its largest provides 54% of grant income and the top three 100%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC.
Largest funder’s share by year: 2017 100% · 2018 51% · 2019 100% · 2020 100% · 2021 100% · 2022 53% · 2023 80% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC draws 62% of its grant income from funders outside Florida, across 2 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $49k arriving through sponsors registered in 2 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC runs a healthier operating margin than half of the 13,754 health nonprofits its size.
this organization peer median middle 50% of peers· 13,754 health nonprofits $100k–$1M, FY2024
Organizations like SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Florida
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
42% of spending goes to programs.
Governance
Public support
100%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Screen this organization
A dated, signed PDF of the compliance screen for SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC?
- SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC (Florida) receives grants from 4 organizations whose IRS filings report $408,896 to it, the largest being Pediatric Brain Tumor Foundation of the United States Inc ($222,633). 4 of them have funded it in more than one year.
- How many funders does SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC have?
- IRS filings report 4 organizations giving $408,896 in grants to SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC, 4 of which have funded it in more than one year.
- Who is the largest funder of SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC?
- Pediatric Brain Tumor Foundation of the United States Inc is the largest funder on record, with $222,633 in grants. The full list of funders is on this page.
- How can an organization like SYDNEY'S INCREDIBLE DEFEAT OF EWING'S SARCOMA INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Florida. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 4 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing